Abstract:The trigeminal ganglion (TG) is the primary site of aberration in trigeminal neuralgia (TN), and hence a crucial site where afferent input can be modulated. Here, we postulated that inhibiting TG via optogenetics using flexible optic cannula would diminish brainstem trigeminal nucleus caudalis (TNC) neuronal activity and pain behavior in TN rat model. Infraorbital nerve constriction was employed to induce TN in female Sprague-Dawley rats, while naive and sham rats served as controls. TG-directed microinjection… Show more
“…We followed the stereotaxic technique to inject the optogenetic virus into TG as mentioned in earlier studies [ 51 , 52 ]. In addition, we employed flexible optic fiber to modulate the TG activity upon stimulation, which ensures high-quality coupling and durability [ 38 ]. Specific targeting and understanding of the molecular perspectives in trigeminal ganglion may help highlight the potential therapeutic intervention in orofacial neuropathic pain.…”
Section: Discussionmentioning
confidence: 99%
“…We have demonstrated that thalamic relay nuclei and the trigeminal brainstem, which direct to the somatosensory cortex, are modified by halorhodopsin-mediated inhibition of TG. Additionally, we highlighted that the inhibition has a significant impact on bursting activity and that thehyperpolarization results in a general reduction in thalamic discharge [ 38 ].…”
Excruciating trigeminal neuralgia (TN) management is very difficult and severely affects the patient’s quality of life. Earlier studies have shown that the trigeminal ganglion (TG) comprises several receptors and signal molecules that are involved in the process of peripheral sensitization, which influences the development and persistence of neuropathic pain. Targeting TG can modulate this sensitization pathway and mediate the pain-relieving effect. So far,there are few studies in which modulation approaches to TG itself have been suggested so far. “Trigeminal ganglion modulation” and “trigeminal neuralgia” were used as search phrases in the Scopus Index and PubMed databases to discover articles that were pertinent to the topic. In this review, we address the role of the trigeminal ganglion in TN and underlying molecules and neuropeptides implicated in trigeminal pain pathways in processing pathological orofacial pain. We also reviewed different modulation approaches in TG for TN management. Furthermore, we discuss the prospect of targeting trigeminal ganglion to manage such intractable pain.
“…We followed the stereotaxic technique to inject the optogenetic virus into TG as mentioned in earlier studies [ 51 , 52 ]. In addition, we employed flexible optic fiber to modulate the TG activity upon stimulation, which ensures high-quality coupling and durability [ 38 ]. Specific targeting and understanding of the molecular perspectives in trigeminal ganglion may help highlight the potential therapeutic intervention in orofacial neuropathic pain.…”
Section: Discussionmentioning
confidence: 99%
“…We have demonstrated that thalamic relay nuclei and the trigeminal brainstem, which direct to the somatosensory cortex, are modified by halorhodopsin-mediated inhibition of TG. Additionally, we highlighted that the inhibition has a significant impact on bursting activity and that thehyperpolarization results in a general reduction in thalamic discharge [ 38 ].…”
Excruciating trigeminal neuralgia (TN) management is very difficult and severely affects the patient’s quality of life. Earlier studies have shown that the trigeminal ganglion (TG) comprises several receptors and signal molecules that are involved in the process of peripheral sensitization, which influences the development and persistence of neuropathic pain. Targeting TG can modulate this sensitization pathway and mediate the pain-relieving effect. So far,there are few studies in which modulation approaches to TG itself have been suggested so far. “Trigeminal ganglion modulation” and “trigeminal neuralgia” were used as search phrases in the Scopus Index and PubMed databases to discover articles that were pertinent to the topic. In this review, we address the role of the trigeminal ganglion in TN and underlying molecules and neuropeptides implicated in trigeminal pain pathways in processing pathological orofacial pain. We also reviewed different modulation approaches in TG for TN management. Furthermore, we discuss the prospect of targeting trigeminal ganglion to manage such intractable pain.
“…Following ION constriction or sham surgery, anesthetized rats were mounted on a stereotaxic platform for virus injection into our designated brainstem region (TNC). The rat's body temperature was maintained at 36 °C with the aid of a heating pad, and each group received the appropriate viral injection following the previous protocol [ 23 , 24 ]. The coordinates were defined as mediolateral (ML) from the midline, anterior–posterior (AP) from the bregma, and dorsoventral (DV) from the brain's pial surface.…”
The significance of hyperactive astrocytes in neuropathic pain is crucial. However, the association between medullary astrocytes and trigeminal neuralgia (TN)-related pain processing is unclear. Here, we examined how optogenetic inhibition of medullary astrocytes in the trigeminal nucleus caudalis (TNC) regulates pain hypersensitivity in an infraorbital nerve (ION) constricted TN model. We used adult Sprague Dawley rats subjected to infraorbital nerve (ION) constriction to mimic TN symptoms, with naive and sham rats serving as controls. For in vivo optogenetic manipulations, rats stereotaxically received AAV8-GFAP-eNpHR3.0-mCherry or AAV8-GFAP-mCherry at the trigeminal nucleus caudalis (TNC). Open field, von Frey, air puff, and acetone tests measured pain behavioral flexibility. In vivo thalamic recordings were obtained simultaneously with optogenetic manipulation in the TNC. Orofacial hyperalgesia and thalamic hyperexcitability were both accompanied by medullary astrocyte hyperactivity, marked by upregulated GFAP. The yellow laser-driven inhibition of TNC astrocytes markedly improved behavioral responses and regulated thalamic neuronal responses. Halorhodopsin-mediated inhibition in medullary astrocytes may modify the nociceptive input transmitted through the trigeminothalamic tract and pain perception. Taken together, these findings imply that this subpopulation in the TNC and its thalamic connections play a significant role in regulating the trigeminal pain circuitry, which might aid in the identification of new therapeutic measures in TN management.
Graphical Abstract
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.